A Safety Study of Contralateral Eye Dosing of VGR-R01 in Participants With Bietti's Crystalline Dystrophy (BCD)

Starting soon · Phase 1/Phase 2

Conditions studied: Bietti Crystalline Dystrophy

In brief

This is a multi-centre, single- arm, non-randomized, open-label phase 1/2 clinical trial which enables dosing of the fellow eyes of patients who received VGR-R01 administration in previous studies.

Key facts

Study ID

NCT07586306

Run by

Shanghai Vitalgen BioPharma Co., Ltd.

People needed

15

Starts

2026-06-01

Expected to finish

2031-07-31

Last updated by the study team

2026-05-14

Who can join

Age: 18 and older, up to 69. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Beijing Tongren Hospital — Beijing, Beijing Municipality, China
• Shanghai General Hospital (Shanghai First People's Hospital) — Shanghai, Shanghai Municipality, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.